Recently, DoseID’s president, Tim Kress-Spatz, discussed RFID’s promise in downstream supply-chain tracking, the importance of interoperability in tracing drugs, reducing the inventory management burden for hospitals, and more on The Pharmaceutical Commerce Podcast. This wide ranging discussion included: Increase in Market Demand for RFID RFID (radio frequency identification) tagged medications are gaining traction again in the pharmaceutical supply chain. Initially,

DoseID, the first member driven industry consortium for the use of radio-frequency identification (RFID) technology in the healthcare space, is excited to be an Association Partner for AIM and RAIN’s Engage Again virtual conference. The conference, taking place virtually on May 5-6, 2021, will focus on the Automatic Data Collection industry and will bring together speakers and exhibitors to cover

This month, DoseID holds our first member meeting on November 19th. As a pharmaceutical industry consortium focused on RFID-enabled drugs and systems, DoseID includes representatives from drug manufacturers, pharmacy automation vendors, RFID inlay manufacturers, label makers, and healthcare providers. A major goal of DoseID is to bring the sometimes fragmented pharmaceutical industry together to unify around the best approach to

In Part 1 of this series, we looked at the difference between storing the drug’s entire dataset of attributes and history on the vial or syringe label vs. storing only a serial number on the label and using that unique number as an identifier to lookup all of the drug’s data in a database. In this post, we’ll build on

Imagine if the DMV didn’t maintain a database of drivers and their driving history. Instead, they just printed all the important information on your driver’s license — such as your name, date of birth, and preferences for organ donation — and relied on each driver to carry their license at all times. Now, imagine if someone got pulled over for